AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Total earnings after all expenses, taxes, and interest
3Y CAGR
+9.6%/yr
vs +2.2%/yr prior
5Y CAGR
+4.1%/yr
Recent acceleration
Acceleration
+7.4pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $34.86B | +9.9% |
| 2024 | $31.73B | +64.6% |
| 2023 | $19.27B | -27.2% |
| 2022 | $26.48B | -50.4% |
| 2021 | $53.35B | +87.5% |
| 2020 | $28.45B | +20.3% |
| 2019 | $23.65B | -2.4% |
| 2018 | $24.23B | +5.3% |
| 2017 | $23.02B | +13.7% |
| 2016 | $20.25B | - |